![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
http://www.drug-dev.com/Main/Back-Issues/HCV-MARKET-Recent-Success-in-HCV-Treatment-Brings-1213.aspx
http://www.fiercepharma.com/pharma-asia/japan-s-pmda-reviews-hep-b-risk-link-to-hep-c-therapies
http://www.reuters.com/article/us-eu-hepatitis-c-idUSKCN0XC1MB
http://www.fiercepharmamarketing.com/story/switching-study-gives-celltrion-biosim-more-ammo-fight-remicade-share/2016-03-21
http://www.fiercepharma.com/story/jj-chief-gorsky-suffers-cuts-bonus-incentive-pay-still-racks-238m/2016-03-17
http://www.fiercepharma.com/story/jjs-new-launches-deliver-overall-sales-fall-short-hep-c-strong-dollar/2016-01-26
http://www.fiercepharma.com/story/more-formulary-exclusions-are-their-way-smaller-pbms-get-action/2015-12-02
http://www.bloomberg.com/news/articles/2015-11-05/gilead-abbvie-asked-by-medicaid-for-hepatitis-c-pricing-options
http://blogs.wsj.com/pharmalot/2015/05/20/will-the-jj-deal-with-achillion-transform-the-hep-c-market/
http://www.fiercepharma.com/story/jj-promises-new-uses-old-meds-keep-pharma-sales-flying-high/2015-05-20
http://www.fiercepharma.com/story/abbvie-moves-closer-japans-crowded-hep-c-field-priority-review-nod/2015-04-16
http://blogs.wsj.com/pharmalot/2015/04/14/why-did-prescription-drug-spending-hit-374b-in-the-us-last-year-read-this/
http://www.pmlive.com/pharma_news/sovaldi_pushes_gilead_to_the_top_of_us_pharma_list_712978
http://www.bloomberg.com/news/articles/2015-04-14/johnson-johnson-profit-exceeds-estimates-as-drug-sales-rise
http://www.fiercepharma.com/story/currency-hurts-olysio-plummets-jj-pharma-growth-carries/2015-04-14
http://www.pmlive.com/pharma_news/gilead_under_fire_for_sovaldi_anti-diversion_policy_710447
http://www.wsj.com/articles/gileads-1-000-hep-c-pill-is-hard-for-states-to-swallow-1428525426
http://www.pmlive.com/pharma_news/j_and_j_chief_predicts_10_new_pharma_filings_by_2017_635856
http://www.pharmatimes.com/Article/15-01-15/Janssen_offers_NHS_to_pay_for_Olysio_failures.aspx
http://www.pmlive.com/pharma_news/nice_backs_new_hepatitis_c_treatments_631606
http://www.fiercepharma.com/story/gilead-appeal-india-patent-ruling-niche-sovaldi-claim/2015-01-16
http://www.fiercepharma.com/story/janssen-agrees-rebate-cost-olysio-englands-nhs-if-it-doesnt-work/2015-01-16
http://www.fiercepharma.com/story/get-ready-negotiate-drugmakers-payers-are-armed-drug-pricing-battle/2014-12-24
http://www.fiercepharma.com/story/ca-panel-gileads-harvoni-cost-effective-95k-only-affordable-half-price/2014-12-15
http://www.Prnewswire.com/news-releases/class-action-lawsuit-challenges-the-exorbitant-pricing-of-gileads-hepatitis-c-drug-sovaldi-300007372.html